1983 related articles for article (PubMed ID: 16011977)
1. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
2. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
4. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.
McCabe DJ; Harrison P; Sidhu PS; Brown MM; Machin SJ
Br J Haematol; 2004 Sep; 126(6):861-9. PubMed ID: 15352991
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
7. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
[TBL] [Abstract][Full Text] [Related]
10. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
[TBL] [Abstract][Full Text] [Related]
11. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
[TBL] [Abstract][Full Text] [Related]
12. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
[TBL] [Abstract][Full Text] [Related]
13. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
16. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
[TBL] [Abstract][Full Text] [Related]
17. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119
[TBL] [Abstract][Full Text] [Related]
18. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
19. Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
Godeneche G; Sorel N; Ragot S; Chomel JC; Neau JP; Macchi L
Platelets; 2009 Nov; 20(7):471-7. PubMed ID: 19852685
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
